Skip to main content
    Zurvek

    ACCESS // CLEARANCE TIERS

    Zurvek Pricing — Tiers for VCs and Private Equity

    Four tiers. All charged in INR — USD shown for reference. Founder access is available anytime through OriZin.

    Zurvek offers four access tiers charged in INR, with reference currency shown where applicable. Founder access runs through OriZin as a one-time purchase. Explorer includes five lifetime evaluations; Analyst and Syndicate provide monthly evaluation allowances; Institutional terms and limits are shown in the current pricing cards. Planned features are listed on the Roadmap rather than included as shipped plan capabilities.

    Access

    Choose the review capacity.

    EXPLORER

    FREE
    ₹05 evaluations · free · lifetime
    Free

    First contact with adversarial intelligence.

    • ›5 evaluations (free, lifetime)
    • ›Five adversarial roles in one structured debate
    • ›Evidence-Adjusted Risk Signal (0-100)
    • ›3 deal-breakers + 3 strengths
    • ›Zero-Inference Protocol
    • ›Geopolitical DEFCON status
    • ›Investment Memo on screen (download on paid tiers)
    • ›CENTRA — 10 questions (lifetime)
    START FREE

    ANALYST

    ACTIVE DEALFLOW
    ₹15,999/month · ₹320 per evaluation
    ≈ $199 · billed in INR

    Active deal flow. Individual investor or solo GP.

    • ›50 evaluations/month
    • ›Full 12-page Investment Memo
    • ›IC Question Generator
    • ›ForensicAuditLog with confidence scoring
    • ›Document Authenticity Analysis (with uploaded documents)
    • ›Claim-Level Confidence Scoring
    • ›Cohort Rank view (Pipeline)
    • ›Weekly Signal Digest
    • ›Deal Velocity Benchmark (your account history)
    GET ANALYST ACCESS

    SYNDICATE

    POPULAR
    ₹34,999/month · ₹117 per evaluation
    ≈ $419 · billed in INR

    Deal leads, GPs, small fund committees.

    • ›300 evaluations/month
    • ›Verdict Integrity Certificate
    • ›MCA21 Discrepancy Flags (manual verification links)
    • ›Revenue Claim Triangulation
    • ›GST Compliance Prompts
    • ›Agent Contradiction Map
    • ›Multi-seat team access (3 seats)
    • ›Batch Analytics Dashboard
    • ›LP-Reportable Quarterly Verdict Export
    • ›Slack + Email Webhook Alerts
    • ›Portfolio Thesis Drift Alerts
    • ›Investment Mandate Settings
    GET SYNDICATE ACCESS

    INSTITUTIONAL

    ENTERPRISE
    ₹83,999/month · Custom volume
    ≈ $999 · billed in INR

    Custom institutional access and volume terms.

    • ›Custom evaluation allowance
    • ›Vault portfolio records (early access)
    • ›SEBI/RBI Adverse History Check (guided, source-linked)
    • ›Custom Rubric Overlay
    • ›Reviewer Assignment Module
    • ›Multi-seat (unlimited seats)
    • ›Evidence Upload Expansion (bank statements, cap table, MCA filings)
    • ›Founder-Provided Context (before a new evaluation)
    REQUEST ACCESS

    Custom allowance and fair-use terms are agreed in the contract.

    Raising, not investing?

    ORIZIN — FOUNDER ACCESS

    The same adversarial engine investors use, turned on your own deck before they see it.

    • ›5 free evaluations, then 30 additional
    • ›Deal-breakers and strengths on every round
    • ›Investment memo download on paid access
    • ›One-time payment — no subscription
    ₹3,999one-time
    30 evaluations · after your 5 free
    See OriZin

    Start free · pay only if you continue

    Planned features are listed on the Roadmap, not here.

    Availability

    Available, Early access, and Planned mean different things.

    Available features are usable now on the stated plan. Early access is limited to selected eligible accounts. Planned work appears only on the Roadmap and is not an included paid benefit. Vault is Early access; the Geopolitical Console is Available; Zurvek MCP is Planned.

    View the Roadmap →

    Zurvek MCP is in development. When it opens, calling the engine from a compatible assistant will run against these same tier limits — no separate plan. What is planned →

    Need custom limits or dedicated infrastructure? Contact enterprise sales

    Zurvek provides risk–return classification and decision-support insights. It does not provide investment advice, recommendations, or solicit transactions.